01 1Emcure Pharmaceuticals
01 1ADENOSINE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-06-18
Pay. Date : 2019-05-15
DMF Number : 33871
Submission : 2019-05-21
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ADENOSINE USP, with a corresponding US DMF Number 33871.
Remarkably, this DMF maintains an Active status since its submission on May 21, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 18, 2019, and payment made on May 15, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
